This article is more than 5 years old. Information may no longer be current.
Balloon Dilatation Catheter Cleared, Launched in US
Boston Scientific’s Emerge Percutaneous Transluminal Coronary Angioplasty Balloon Dilatation Catheter has received FDA clearance and is currently being marketed in the United States.
The next-generation pre-dilatation balloon catheter is designed specifically to offer enhanced deliverability to challenging lesions in coronary arteries. It is available in balloon diameters from 1.5 mm to 4 mm, with balloon lengths ranging from 8 mm to 30 mm.
According to a press release issued by the manufacturer, both the Monorail and OTW catheter are available with two distinct shaft technologies designed to provide versatility in addressing different clinical situations: The “Push Technology” (1.5 mm) offers a single-segment inner shaft for enhanced pushability, and the “Workhorse Technology” (1.5 mm-4 mm) features a bi-segment inner shaft designed for excellent deliverability without sacrificing push.
The Emerge Catheter was commercially released in CE mark countries earlier this year.